{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:11:46Z","timestamp":1780499506078,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005274","name":"North-West University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005274","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Abnormal-glucose tolerance (Abnl-GT) is due to an imbalance between \u03b2-cell function and insulin resistance (IR) and is a major risk factor in cardiovascular disease (CVD). In sub-Saharan Africa, \u03b2-cell failure is emerging as an important cause of Abnl-GT (Abnl-GT-\u03b2-cell-failure). Visceral adipose tissue (VAT) volume and hyperlipidemia are major contributors to CVD risk when Abnl-GT is due to IR (Abnl-GT-IR). Yet, the CVD profile associated with Abnl-GT-\u03b2-cell failure is unknown. Therefore, our goals in 450 African-born Blacks (Male: 65%; Age: 39 \u00b1 10 years; BMI 28 \u00b1 5\u00a0kg\/m<jats:sup>2<\/jats:sup>), living in America were to: (1) determine Abnl-GT prevalence and etiology; (2) assess by Abnl-GT etiology, associations between four understudied subclinical CVD risk factors in Africans: (a) subclinical myocardial damage (high-sensitivity troponin T (hs-cTnT)); (b) neurohormonal regulation (N-terminal pro-Brain-natriuretic peptide (NT-proBNP)); (c) coagulability (fibrinogen); (d) inflammation (high-sensitivity C-reactive protein (hsCRP)), as well as HbA<jats:sub>1c<\/jats:sub>, Cholesterol\/HDL ratio and VAT. Glucose tolerance status was determined by the OGTT. IR was defined by the threshold at the lowest quartile for the Matsuda Index (\u2264 2.97). Abnl-GT-IR required both Abnl-GT and IR. Abnl-GT-\u03b2-cell-failure was defined as Abnl-GT without IR. VAT was assessed by CT-scan. For both the Abnl-GT-\u03b2-cell-failure and Abnl-GT-IR groups, four multiple regression models were performed for hs-cTnT; NT-proBNP; fibrinogen and hsCRP, as dependent variables, with the remaining three biomarkers and HbA<jats:sub>1c<\/jats:sub>, Cholesterol\/HDL and VAT as independent variables. Abnl-GT occurred in 38% (170\/450). In the Abnl-GT group, \u03b2-cell failure occurred in 58% (98\/170) and IR in 42% (72\/170). VAT and Cholesterol\/HDL were significantly lower in Abnl-GT-\u03b2-cell-failure group vs the Abnl-GT-IR group (both <jats:italic>P<\/jats:italic> &lt; 0.001). In the Abnl-GT-\u03b2-cell-failure group: significant associations existed between hscTnT, fibrinogen, hs-CRP, and HbA<jats:sub>1c<\/jats:sub> (all <jats:italic>P<\/jats:italic> &lt; 0.05), and none with Cholesterol\/HDL or VAT. In Abnl-GT-IR: hs-cTnT, fibrinogen and hsCRP significantly associated with Cholesterol\/HDL (all <jats:italic>P<\/jats:italic> &lt; 0.05) and NT-proBNP inversely related to fibrinogen, hsCRP, HbA<jats:sub>1c<\/jats:sub>, Cholesterol\/HDL, and VAT (all <jats:italic>P<\/jats:italic> &lt; 0.05). The subclinical CVD risk profile differed between Abnl-GT-\u03b2-cell failure and Abnl-GT-IR. In Abnl-GT-\u03b2-cell failure subclinical CVD risk involved subclinical-myocardial damage, hypercoagulability and increased inflammation, but not hyperlipidemia or visceral adiposity. For Abnl-GT-IR, subclinical CVD risk related to subclinical myocardial damage, neurohormonal dysregulation, inflammation associated with hyperlipidemia and visceral adiposity.\n<\/jats:p><jats:p><jats:bold>ClinicalTrials.<\/jats:bold>gov Identifier: NCT00001853.\n<\/jats:p>","DOI":"10.1038\/s41598-022-19917-8","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T11:58:28Z","timestamp":1665403108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Africans in America study demonstrates that subclinical cardiovascular risk differs by etiology of abnormal glucose tolerance"],"prefix":"10.1038","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct00001853","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Annemarie","family":"Wentzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Grace","family":"Duhuze Karera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arielle C.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe C.","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blayne R.","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian S.","family":"Mabundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"DuBose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margrethe F.","family":"Horlyck-Romanovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"issue":"6","key":"19917_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.108.834408","volume":"119","author":"HC Gerstein","year":"2009","unstructured":"Gerstein, H. C. Dysglycemia and cardiovascular risk in the general population. Circulation 119(6), 773\u2013775 (2009).","journal-title":"Circulation"},{"issue":"1","key":"19917_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal, V. et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol. 17(1), 122 (2018).","journal-title":"Cardiovasc. Diabetol."},{"key":"19917_CR3","doi-asserted-by":"publisher","first-page":"e002447","DOI":"10.1136\/bmjdrc-2021-002447","volume":"9","author":"MCS Ishimwe","year":"2021","unstructured":"Ishimwe, M. C. S. et al. Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: Insight from the Africans in America study. BMJ Open Diabetes Res Care 9, e002447 (2021).","journal-title":"BMJ Open Diabetes Res Care"},{"key":"19917_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40842-019-0077-8","volume":"5","author":"D Kibirige","year":"2019","unstructured":"Kibirige, D. et al. Understanding the manifestation of diabetes in sub Saharan Africa to inform therapeutic approaches and preventive strategies: A narrative review. Clin. Diabetes Endocrinol. 5, 2 (2019).","journal-title":"Clin. Diabetes Endocrinol."},{"key":"19917_CR5","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","volume":"135","author":"SL Seliger","year":"2017","unstructured":"Seliger, S. L. et al. High-sensitivity cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure. Circulation 135, 1494\u20131505 (2017).","journal-title":"Circulation"},{"issue":"2","key":"19917_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2337\/dc16-1541","volume":"40","author":"SP Whelton","year":"2017","unstructured":"Whelton, S. P. et al. High-sensitivity cardiac troponin T (hs-cTnT) as a predictor of incident diabetes in the atherosclerosis risk in communities study. Diabetes Care 40(2), 261\u2013269 (2017).","journal-title":"Diabetes Care"},{"issue":"11","key":"19917_CR7","doi-asserted-by":"publisher","first-page":"e020447","DOI":"10.1161\/JAHA.120.020447","volume":"10","author":"PL Myhre","year":"2021","unstructured":"Myhre, P. L. et al. Diagnostic thresholds for pre-diabetes mellitus and diabetes mellitus and subclinical cardiac disease in the general population: Data from the ACE 1950 study. J. Am. Heart Assoc. 10(11), e020447 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"8","key":"19917_CR8","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/aje\/kwz082","volume":"188","author":"A Wentzel","year":"2019","unstructured":"Wentzel, A., Malan, L., von Kanel, R. & Malan, N. T. Ethnicity-specific changes in cardiac troponin T in response to acute mental stress and ethnicity-specific cutpoints for the R wave of the aVL lead. Am. J. Epidemiol. 188(8), 1444\u20131455 (2019).","journal-title":"Am. J. Epidemiol."},{"key":"19917_CR9","doi-asserted-by":"publisher","first-page":"6647987","DOI":"10.1155\/2021\/6647987","volume":"2021","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. High-sensitivity cardiac troponin T is a risk factor for major adverse cardiovascular events and all-cause mortality: A 9.5-year follow-up study. Cardiol. Res. Pract. 2021, 6647987 (2021).","journal-title":"Cardiol. Res. Pract."},{"key":"19917_CR10","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/hr.2016.45","volume":"39","author":"EJ van Vuren","year":"2016","unstructured":"van Vuren, E. J., von Kaenel, R., Cockeran, M. & Malan, N. T. Hyperpulsatile pressure, systemic inflammation and cardiac stress are associated with cardiac wall remodeling in an African male cohort: The SABPA study. Hypertens. Res. 39, 648\u2013653 (2016).","journal-title":"Hypertens. Res."},{"issue":"5","key":"19917_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/ajh\/hpaa224","volume":"34","author":"CDPTB Nicoli","year":"2021","unstructured":"Nicoli, C. D. P. T. B. et al. N-termianl Pro-B-type natriuretic peptide and longitudinal risk of hypertension. Am. J. Hypertens. 34(5), 476\u2013483 (2021).","journal-title":"Am. J. Hypertens."},{"key":"19917_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1161\/HYPERTENSIONAHA.118.11081","volume":"72","author":"JBAL Jordan","year":"2018","unstructured":"Jordan, J. B. A. L., Melander, O. & Moro, C. Natriuretic peptides in cardiovascular and metabolic crosstalk. Hypertension 72, 270\u2013276 (2018).","journal-title":"Hypertension"},{"issue":"1","key":"19917_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12933-021-01271-0","volume":"20","author":"HH Liu","year":"2021","unstructured":"Liu, H. H. et al. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: A prospective cohort study. Cardiovasc. Diabetol. 20(1), 84 (2021).","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"19917_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/1479164118816221","volume":"16","author":"EJ van Vuren","year":"2019","unstructured":"van Vuren, E. J. et al. Prospective associations between cardiac stress, glucose dysregulation and executive cognitive function in Black men: The sympathetic activity and ambulatory blood pressure in Africans study. Diab. Vasc. Dis. Res. 16(3), 236\u2013243 (2019).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"19917_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","volume":"114","author":"S Blankenberg","year":"2006","unstructured":"Blankenberg, S. et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study. Circulation 114, 201\u2013208 (2006).","journal-title":"Circulation"},{"issue":"1","key":"19917_CR16","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1038\/s41598-021-84046-7","volume":"11","author":"M Lasse","year":"2021","unstructured":"Lasse, M. et al. Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals. Sci. Rep. 11(1), 4605 (2021).","journal-title":"Sci. Rep."},{"issue":"1","key":"19917_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","volume":"34","author":"D Davalos","year":"2012","unstructured":"Davalos, D. & Akassoglou, K. Fibrinogen as a key regulator of inflammation in disease. Semin. Immunopathol. 34(1), 43\u201362 (2012).","journal-title":"Semin. Immunopathol."},{"issue":"1","key":"19917_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-019-0858-5","volume":"18","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: A single-centre, prospective cohort study. Cardiovasc. Diabetol. 18(1), 52 (2019).","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"19917_CR19","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.metabol.2006.03.011","volume":"55","author":"Y Aso","year":"2006","unstructured":"Aso, Y. et al. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism 55(8), 1014\u20131021 (2006).","journal-title":"Metabolism"},{"issue":"3","key":"19917_CR20","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"ADMJE Pradhan","year":"2001","unstructured":"Pradhan, A. D. M. J. E., Rifai, N., Buring, J. E. & Ridker, P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3), 327\u2013334 (2001).","journal-title":"JAMA"},{"issue":"24","key":"19917_CR21","doi-asserted-by":"publisher","first-page":"9405","DOI":"10.3390\/ijerph17249405","volume":"17","author":"EM Shoup","year":"2020","unstructured":"Shoup, E. M. et al. Africans who arrive in the United States before 20 years of age maintain both cardiometabolic health and cultural identity: Insight from the Africans in America study. Int. J. Environ. Res. Public Health 17(24), 9405 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"5","key":"19917_CR22","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.3390\/ijerph19052562","volume":"19","author":"ZC Waldman","year":"2022","unstructured":"Waldman, Z. C. et al. Sleep and economic status are linked to daily life stress in African-Born blacks living in America. Int. J. Environ. Res. Public Health 19(5), 2562 (2022).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"10","key":"19917_CR23","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.2337\/dc20-1119","volume":"43","author":"AF Hobabagabo","year":"2020","unstructured":"Hobabagabo, A. F. et al. Improved detection of abnormal glucose tolerance in Africans: The value of combining hemoglobin A1c with glycated albumin. Diabetes Care 43(10), 2607\u20132613 (2020).","journal-title":"Diabetes Care"},{"key":"19917_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3389\/fendo.2019.00533","volume":"10","author":"SM Briker","year":"2019","unstructured":"Briker, S. M. et al. A1C Underperforms as a diagnostic test in Africans even in the absence of nutritional deficiencies, anemia and hemoglobinopathies: Insight From the Africans in America Study. Front. Endocrinol. (Lausanne) 10, 533 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"19917_CR25","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6), e13\u2013e115 (2018).","journal-title":"Hypertension"},{"key":"19917_CR26","unstructured":"Organization WH. Obesity and Overweight [Fact Sheet]. WHO. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight. (2020) (Accessed 1 April 2020)."},{"issue":"3","key":"19917_CR27","first-page":"53","volume":"23","author":"JSM Patry-Parisien","year":"2012","unstructured":"Patry-Parisien, J. S. M. & Bryan, S. Comparison of waist circumference using the World Health Organization and National Institutes of Health protocols. Health Rep. 23(3), 53\u201360 (2012).","journal-title":"Health Rep."},{"key":"19917_CR28","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"ASSLA Levey","year":"2009","unstructured":"Levey, A. S. S. L. A. et al. A new equation to calculate estimated glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"19917_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/met.2014.0026","volume":"12","author":"MY O'Connor","year":"2014","unstructured":"O\u2019Connor, M. Y. et al. Worse cardiometabolic health in African immigrant men than African American men: Reconsideration of the healthy immigrant effect. Metab. Syndr. Relat. Disord. 12(6), 347\u2013353 (2014).","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"9","key":"19917_CR30","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"MDRA Matsuda","year":"1999","unstructured":"Matsuda, M. D. R. A. INsulin sensitivity indices obtained from the oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 22(9), 1462\u20131470 (1999).","journal-title":"Diabetes Care"},{"issue":"2","key":"19917_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2337\/dc08-1478","volume":"32","author":"KMPR Utzschneider","year":"2009","unstructured":"Utzschneider, K. M. P. R. et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32(2), 335\u2013341 (2009).","journal-title":"Diabetes Care"},{"issue":"6","key":"19917_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WTLRI Friedewald","year":"1972","unstructured":"Friedewald, W. T. L. R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"issue":"1","key":"19917_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1185\/030079908X253573","volume":"24","author":"LHHBG Curtis","year":"2008","unstructured":"Curtis, L. H. H. B. G. et al. Pancreatic B-cell function as a predictor of cardiovascular outcomes and costs: Findings from the cardiovascular health study. Curr. Med. Res. Opin. 24(1), 41\u201350 (2008).","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"19917_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jchf.2014.05.017","volume":"2","author":"CE Ndumele","year":"2014","unstructured":"Ndumele, C. E. et al. Obesity, subclinical myocardial injury, and incident heart failure. JACC Heart Fail. 2(6), 600\u2013607 (2014).","journal-title":"JACC Heart Fail."},{"issue":"5","key":"19917_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12975-018-0673-4","volume":"10","author":"AML Wentzel","year":"2019","unstructured":"Wentzel, A. M. L., Smith, W., von K\u00e4nel, R. & Malan, N. T. Retinal vasculature reactivity during flicker light provocation, cardiac stress and stroke risk in Africans: The SABPA study. Transl. Stroke Res. 10(5), 485\u2013494 (2019).","journal-title":"Transl. Stroke Res."},{"issue":"2","key":"19917_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40200-019-00460-9","volume":"18","author":"S Simic","year":"2019","unstructured":"Simic, S., Svagusa, T., Prkacin, I. & Bulum, T. Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events. J. Diabetes Metab. Disord. 18(2), 693\u2013704 (2019).","journal-title":"J. Diabetes Metab. Disord."},{"key":"19917_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","volume":"90","author":"I Russo","year":"2016","unstructured":"Russo, I. & Frangogiannis, N. G. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. J. Mol. Cell Cardiol. 90, 84\u201393 (2016).","journal-title":"J. Mol. Cell Cardiol."},{"key":"19917_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-015-0224-1","volume":"14","author":"S Ahmadi-Abhari","year":"2015","unstructured":"Ahmadi-Abhari, S., Kaptoge, S., Luben, R. N., Wareham, N. J. & Khaw, K. Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: The European Prospective Investigation into Cancer\u2014Norfolk study. Cardiovasc. Diabetol. 14, 1 (2015).","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"19917_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.acvd.2020.06.006","volume":"113","author":"S Battault","year":"2020","unstructured":"Battault, S. et al. Myocardial glucotoxicity: Mechanisms and potential therapeutic targets. Arch. Cardiovasc. Dis. 113(11), 736\u2013748 (2020).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"19917_CR40","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2337\/db14-1903","volume":"64","author":"L Marzban","year":"2015","unstructured":"Marzban, L. New insights into the mechanisms of islet inflammation in type 2 diabetes. Diabetes 64, 1094\u20131097 (2015).","journal-title":"Diabetes"},{"issue":"2","key":"19917_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4239\/wjd.v5.i2.89","volume":"5","author":"Q Sun","year":"2014","unstructured":"Sun, Q., Li, J. & Gao, F. New insights into insulin: The anti-inflammatory effect and its clinical relevance. World J. Diabetes 5(2), 89\u201396 (2014).","journal-title":"World J. Diabetes"},{"key":"19917_CR42","doi-asserted-by":"publisher","first-page":"e001057","DOI":"10.1136\/bmjgh-2018-001057","volume":"3","author":"DJ Kabakambira","year":"2018","unstructured":"Kabakambira, D. J. et al. Do current guidelines for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America. BMJ Glob. Health 3, e001057 (2018).","journal-title":"BMJ Glob. Health"},{"issue":"2","key":"19917_CR43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/jc.2015-3246","volume":"101","author":"YCFWY Hwang","year":"2015","unstructured":"Hwang, Y. C. F. W. Y., Hayashi, T., Kahn, S. E., Leonetti, D. L. & Boyko, E. J. Increased visceral adipose tissue is an independent predictor for future development of atherogenic dyslipidemia. J. Clin. Endocrinol. Metab. 101(2), 678\u2013685 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"19917_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/03007995.2017.1364226","volume":"34","author":"L Liu","year":"2018","unstructured":"Liu, L. et al. Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes. Curr. Med. Res. Opin. 34(1), 123\u2013129 (2018).","journal-title":"Curr. Med. Res. Opin."},{"issue":"24","key":"19917_CR45","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","volume":"139","author":"P Welsh","year":"2019","unstructured":"Welsh, P. et al. Cardiac troponin T and troponin I in the general population. Circulation 139(24), 2754\u20132764 (2019).","journal-title":"Circulation"},{"issue":"11","key":"19917_CR46","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/jamacardio.2020.2996","volume":"5","author":"HD White","year":"2020","unstructured":"White, H. D. Clinically important improvements in risk assessment by adding high-sensitivity troponin level to cholesterol guidelines. JAMA Cardiol. 5(11), 1263\u20131264 (2020).","journal-title":"JAMA Cardiol."},{"key":"19917_CR47","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2019\/42041.13162","author":"D Nath","year":"2019","unstructured":"Nath, D., Shivashekar, M. & Vinodhini, V. M. Fibrinogen levels in obese and normal individuals. J. Clin. Diagn. Res. https:\/\/doi.org\/10.7860\/JCDR\/2019\/42041.13162 (2019).","journal-title":"J. Clin. Diagn. Res."},{"issue":"2","key":"19917_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/nu11020298","volume":"11","author":"S Galmes","year":"2019","unstructured":"Galmes, S., Cifre, M., Palou, A., Oliver, P. & Serra, F. A genetic score of predisposition to low-grade inflammation associated with obesity may contribute to discern population at risk for metabolic syndrome. Nutrients 11(2), 298 (2019).","journal-title":"Nutrients"},{"key":"19917_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0021-9150(99)00373-1","volume":"150","author":"EP-MA Raynaud","year":"2000","unstructured":"Raynaud, E.P.-M.A., Brun, J. F., Aissa-Benhaddad, A., Fedou, C. & Mercier, J. Relationships between fibrinogen and insulin resistance. Atherosclerosis 150, 365\u201370 (2000).","journal-title":"Atherosclerosis"},{"issue":"10","key":"19917_CR50","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1210\/jc.2011-1182","volume":"96","author":"AMCS Khan","year":"2011","unstructured":"Khan, A. M. C. S. et al. Cardiac natriuretic peptides, obesity and insulin resistance: Evidence from two community-based studies. J. Clin. Endocrinol. Metab. 96(10), 3242\u20133249 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"19917_CR51","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1253\/circj.CJ-15-0589","volume":"79","author":"DK Gupta","year":"2015","unstructured":"Gupta, D. K. & Wang, T. J. Natriuretic peptides and cardiometabolic health. Circ. J. 79(8), 1647\u20131655 (2015).","journal-title":"Circ. J."},{"issue":"5","key":"19917_CR52","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/10641963.2016.1151524","volume":"38","author":"EJ van Vuren","year":"2016","unstructured":"van Vuren, E. J. et al. Fibrosis and coronary perfusion\u2014A cardiovascular disease risk in an African male cohort: The SABPA study. Clin. Exp. Hypertens. 38(5), 482\u2013488 (2016).","journal-title":"Clin. Exp. Hypertens."},{"issue":"8","key":"19917_CR53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1503\/cmaj.091551","volume":"182","author":"MI Creatore","year":"2010","unstructured":"Creatore, M. I. et al. Age- and sex-related prevalence of diabetes mellitus among immigrants to Ontario, Canada. CMAJ 182(8), 781\u2013789 (2010).","journal-title":"CMAJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19917-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T14:07:06Z","timestamp":1665410826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-19917-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["19917"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-19917-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16947"}}